Olmesartan Duo Tablet 20/5 mg

Adult dose

The recommended initial dose of olmesartan medoxomil is 10mg once daily, administered irrespective of food. If blood pressure is not adequately controlled, the dose may be increased to 20mg once daily, with a maximum dose of 40mg per day. The antihypertensive effect appears within 2 weeks of initiating treatment, with maximum effect seen around 8 weeks. If blood pressure is not adequately controlled with this medication alone, it may be combined with thiazide diuretics.

Child dose

The safety and efficacy for pediatric patients under 18 years have not been established.

This medication can cause severe harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. This medication should not be used by women who are allergic to any of the components, pregnant or breastfeeding women, patients with severely impaired kidney or liver function, and patients with certain muscle disorders. In particular, women of childbearing potential should ensure adequate contraception to avoid pregnancy and should only take this medication after fully understanding the risks to the fetus, even if the likelihood of pregnancy is low. Caution should be exercised when administering this medication to patients with reduced kidney function or blood volume, as it may lead to hypotension or impaired kidney function. Due to the risk of hyperkalemia, serum potassium levels should be regularly monitored and managed. This medication may affect liver function, so caution is necessary for patients with a history of liver disease or abnormal liver function test results, and repeated liver function tests may be needed as necessary. If symptoms such as muscle pain or weakness occur, contact a healthcare professional immediately to check for possible muscle damage through blood tests. Extra caution is advised for patients with a history of excessive alcohol consumption or liver disease. Dizziness or drowsiness may occur during treatment, so it is advisable to avoid driving or operating hazardous machinery. Moreover, this medication may interact with certain other medications; therefore, if other medications are being taken, consult a physician or pharmacist. It is safest for pregnant and breastfeeding women not to take this medication; if breastfeeding, either cessation of breastfeeding or stopping the medication should be considered. The safety and efficacy of this medication for children and adolescents under 18 years have not been established, so use is not recommended. Elderly patients may have increased concentrations of this medication in the body, so dose adjustment and careful monitoring are necessary. In case of overdose, symptoms such as hypotension and palpitations may appear, and immediate medical treatment should be sought. This medication should be stored out of reach of children and not transferred to another container.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headache, lightning headache, seizures, altered consciousness, visual disturbances, paralysis, urination

Mild side effects

• Headache
• dizziness
• decreased perception
• drowsiness
• gastroesophageal reflux
• constipation
• tooth decay
• dyspepsia
• gastric ulcer
• gastritis

This medication should be stored in a tightly closed container to protect against air and moisture and should be kept at room temperature between 1 and 30 degrees Celsius. Proper storage can help maintain the effectiveness of the medication for a longer period.

Appearance

White or pale yellow round film-coated tablets

Package unit

30 tablets/box [10 tablets/Alu-Alu x 3]